Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

Daniel O. Persky,Hongli Li,Deborah M. Stephens,Steven I. Park,Nancy L. Bartlett,Lode J. Swinnen,Paul M. Barr,Jerome D. Winegarden,Louis S. Constine,Thomas J. Fitzgerald,John P. Leonard,Brad S. Kahl,Michael LeBlanc,Joo Y. Song,Richard I. Fisher,Lisa M. Rimsza,Sonali M. Smith,Thomas P. Miller,Jonathan W. Friedberg

Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

2020

Daniel O. Persky
Hongli Li
Deborah M. Stephens
Steven I. Park
Nancy L. Bartlett
Lode J. Swinnen
Paul M. Barr
Jerome D. Winegarden
Louis S. Constine
Thomas J. Fitzgerald
John P. Leonard
Brad S. Kahl
Michael LeBlanc
Joo Y. Song
Richard I. Fisher
Lisa M. Rimsza
Sonali M. Smith
Thomas P. Miller
Jonathan W. Friedberg

PURPOSEDiffuse large B-cell lymphoma (DLBCL) presents as a limited-stage disease in 25% to 30% of patients, with better overall survival (OS) than that for advanced-stage disease but with continuou...

Keywords:

Medicine
Radiology
overall survival
Diffuse large B-cell lymphoma
Limited Stage
Positron emission tomography
Pathology
Lymphoma
Disease
Clinical trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations